# Acetylcarnitine and Insulin Sensitivity

> **NCT00393770** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 43 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** L-acetylcarnitine

## Key facts

- **NCT ID:** NCT00393770
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-10
- **Final completion:** 2007-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2011-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393770, "Acetylcarnitine and Insulin Sensitivity". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00393770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*